Top Tweets for #GBT601

over 4 years ago

#GBT601 (aka GBT021601), a haemoglobin O2 affinity modifier, improved Hb, lowered hemolytic markers, improved point of sickling (PoS) on O2 gradient ektacytometry in phase 1 study of SCD patients #EHA2022 Brown C, et al. HemaSphere, 2022;6(S3):S268 https://t.co/iqEKHUPQ3D

CaptainAV's tweet photo. #GBT601 (aka GBT021601), a haemoglobin O2 affinity modifier, improved Hb, lowered hemolytic markers, improved point of sickling (PoS) on O2 gradient ektacytometry in phase 1 study of SCD patients
#EHA2022
Brown C, et al. HemaSphere, 2022;6(S3):S268
https://t.co/iqEKHUPQ3D https://t.co/mmdIaPdcPz

stock setter

@MarcJacksonLA

over 4 years ago

$GBT Multiple daily doses of GBT601, Global Blood Therapeutics’ experimental oral therapy for sickle cell disease (SCD), were generally well tolerated and showed promising pharmacological and efficacy signals in six patients #GBT #GBT021601 #GBT601 https://t.co/UtK6E9Sxm1

Top Tweets for #GBT601

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users